Atlas Trials

Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

Clinical trial NCT00297167 · COMPLETED

Trial details

NCT number
NCT00297167
Sponsor
Forest Laboratories
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cystic FibrosisExocrine Pancreatic Insufficiency
Start date
2006-05-01
Primary completion
2006-11-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.